Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation
Open Access
- 7 May 2023
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (8) , 505.e1-505.e8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Review of Autologous Stem Cell Transplantation in LymphomaCurrent Hematologic Malignancy Reports, 2017
- What is the role of autologous transplant for lymphoma in the current era?Hematology-American Society Hematology Education Program, 2015
- Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMTBone Marrow Transplantation, 2015
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2015
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantationBone Marrow Transplantation, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factorsBone Marrow Transplantation, 1997